Horm Metab Res 2006; 38(4): 236-240
DOI: 10.1055/s-2006-925337
Review
© Georg Thieme Verlag KG Stuttgart · New York

Sex Hormone-binding Globulin (SHBG) and Estradiol Cross-talk in Breast Cancer Cells

N.  Fortunati1 , M.  G.  Catalano2
  • 1 Oncological Endocrinology, ASO San Giovanni Battista, Turin, Italy
  • 2 Department of Clinical Physiopathology, University of Turin, Turin, Italy
Weitere Informationen

Publikationsverlauf

Received 1 August 2005

Accepted after revision 21 November 2005

Publikationsdatum:
15. Mai 2006 (online)

Abstract

Sex Hormone-binding Globulin (SHBG) is a plasma glycoprotein that regulates the action of steroid hormones at several levels. SHBG regulates the availability of free androgens and estradiol to hormone-responsive tissues. Moreover, SHBG is also part of a novel steroid signaling system. We report here on the mechanism of action and the biological effects of SHBG in breast cancer cells, especially distinguishing cross-talk between membrane-initiated SHBG and estradiol pathways. After interacting with a specific binding site on breast cancer cell membranes, SHBG activates a specific pathway, and by cAMP induction, inhibits estradiol-mediated activation of ERK. Both estradiol and SHBG membrane-initiated pathways involve cross-talk at MAP kinase level with the ultimate result of inhibiting estradiol-mediated cell growth and antiapoptosis. On the basis of reported evidence, we suggest that SHBG is one of the regulators of growth and apoptosis of estrogen-dependent breast cancer cells.

References

  • 1 Hammond G L. Potential functions of plasma steroid-binding proteins.  Trend Endocrinol Metab. 1995;  6 298-340
  • 2 Fortunati N. Sex hormone-binding globulin: not only a transport protein. What news is around the corner?.  J Endocrinol Invest. 1999;  22 223-234
  • 3 Moore J W, Clark G M, Bulbrook R D, Hayword J L, Murai J T, Hammond G L, Siiteri P K. Serum concentrations of total and non-protein bound estardiol in patients withb breast cancer and in normal controls.  Int J Cancer. 1982;  29 17-21
  • 4 Toniolo P G, Levitz M, Zeleniuch-Jaquotte A, Benerjee S, Koenig K L, Shore R E, Strax P, Pasternack B S. A prospective study of endogenous estrogens and breast cancer in postmenopausal women.  J Natl Cancer Inst. 1995;  87 190-197
  • 5 Zeleniuch-Jacquotte A, Shore R E, Koenig K L, Akhmedkhanov A, Afanasyeva Y, Kato I, Kim M Y, Rinaldi S, Kaaks R, Toniolo P. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study.  Br J Cancer. 2004;  90 153-159
  • 6 Lipworth L, Adami H O, Trichopoulos D, Carlstrom K, Mantzoros C. Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer.  Epidemiology. 1996;  7 96-100
  • 7 Key T, Applebay P, Barnes I, Reeves G. Endogenous Hormones and Breast Cancer Collaborative Group . Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.  J Natl Cancer Inst. 2002;  94 606-616
  • 8 Murayama Y, Sakuma T, Udagawa H, Utsunomiya J, Okamoto R, Asano K. Sex hormone-binding globulin and estrogen receptor in breast cancer: technique and preliminary clinical results.  J Clin Endocrinol Metab. 1978;  46 998-1006
  • 9 Murayama Y, Utsunomiya J, Takahashi I, Kitamura M, Tominaga T. Sex hormone binding globulin as a reliable indicator of hormone dependence in human breast cancer.  Ann Surg. 1979;  190 133-138
  • 10 Plymate S R, Stutz F H, Fariss B L. Relationship betweeen sex hormone-binding globulin and estrogen receptors in breast cancer.  J Clin Oncol. 1984;  2 652-654
  • 11 Bordin S, Petra P H. Immunocytochemical localization of the sex steroid-binding protein of plasma in tissues of the adult monkey Macaca Nemestrina.  Proc Natl Acad Sci USA. 1980;  70 5678-5682
  • 12 Tardivel-Lacombe J, Egloff M, Mazabraud A, Degrelle H. Immunohistochemical detection of the sex steroid-binding plasma protein in human mammari carcinoma cells.  Biochem Biophys Res Commun. 1984;  118 488-494
  • 13 Sinnecker G, Hiort O, Mitze M, Donn F, Neumann S. Immunohistochemical localization of sex hormone-binding globulin in normal and neoplastic breast tissue.  Horm Metab Res. 1990;  22 47-50
  • 14 Meyer S, Brumm C, Stegner H E, Sinnecker G H. Intracellular sex hormone binding globulin (SHBG) in normal and neoplastic breast tissue - an additional marker for hormone dependency?.  Exp Clin Endocrinol. 1994;  102 334-340
  • 15 Germain P, Egloff M, Kiefer H, Metezeau P, Habrioux G. Use of confocal microscopy to localize the SHBG interaction with human breast cancer cell lines - a comparison with serum albumin interaction.  Cell Molec Biol. 1997;  43 501-508
  • 16 Moore K H, Bertram K A, Gomez R R, Styner M J, Matej L A. Sex hormone binding globulin mRNA in human breast cancer: detection in cell lines and tumor samples.  J Steroid Biochem Molec Biol. 1996;  59 297-304
  • 17 Strel'chyonok O A, Avvakumov G V, Survilo L I. A recognition system for sex-hormone-binding protein-estradiol complex in human decidual endometrium plasma membranes.  Biochim Biophys Acta. 1984;  802 459-466
  • 18 Fortunati N, Fissore F, Fazzari A, Berta L, Giudici M, Frairia R. Sex steroid-binding protein interacts with a specific receptor on human premenopausal endometrium membrane: modulating effect of estradiol.  Steroids. 1991;  56 341-346
  • 19 Fortunati N, Frairia R, Fissore F, Berta L, Fazzari A, Gaidano G. The receptor for human sex steroid binding protein (SBP) is expressed on membranes of neoplastic endometrium.  J Steroid Biochem Mol Biol. 1992;  42 185-191
  • 20 Hryb D J, Khan M S, Rosner W. Testosterone-estradiol-binding globulin binds to human prostatic cell membranes.  Biochem Biophys Res Commun. 1985;  128 432-440
  • 21 Avvakumov G V, Survilo L I, Strel'chenok O A. Interaction of blood sex steroid-binding globulin with cell membranes of human decidual tissue.  Biokhimiia.. 1985;  50 1155-1161
  • 22 Gueant J L, Fremont S, Felden F, Nicolas J P, Gerard A, Leheup B, Gerard H, Grignon G. Evidence that androgen-binding protein endocytosis in vitro is receptor mediated in principal cells of the rat epididymis.  J Mol Endocrinol. 1991;  7 113-122
  • 23 Caldwell J D. Evidence of sex hormone binding globulin binding sites in the medial preoptic area and hypothalamus.  Horm Metab Res. 2001;  33 7-9
  • 24 Caldwell J D. A sexual arousability model involving steroid effects at the plasma membranes.  Neurosci Biobehav Rev. 2002;  26 13-30
  • 25 Caldwell J D, Walker C H, O’Rourke S T, Faggin B M, Morris M, Mason G A. Analogies between oxytocin systems of the uterus and brain.  Horm Metab Res. 1996;  28 65-74
  • 26 Porto C S, Musto N A, Bardin C W, Gunsalus G L. Binding of an extracellular steroid-binding globulin to membranes and soluble receptors from human breast cancer cells (MCF-7 cells).  Endocrinology. 1992;  130 2931-2936
  • 27 Fortunati N, Fissore F, Fazzari A, Berta L, Benedusi-Pagliano E, Frairia R. Biological relevance of the interaction between sex steroid binding protein and its specific receptor of MCF-7 cells: effect on the estradiol-induced cell proliferation.  J Steroid Biochem Mol Biol. 1993;  45 435-444
  • 28 Hryb D J, Khan M S, Romas N A, Rosner W. Solubilization and partial characterization of the sex hormone-binding globulin receptor from human prostate.  J Biol Chem. 1989;  264 5378-5383
  • 29 Hryb D J, Khan M S, Romas N A, Rosner W. The control of the interaction of sex hormone-binding globulin with its receptor by steroid hormones.  J Biol Chem. 1990;  265 6048-6054
  • 30 Khan M S, Hryb D J, Hashim G A, Romas N A, Rosner W. Delineation and synthesis of the membrane receptor-binding domain of sex hormone-binding globulin.  J Biol Chem. 1990;  265 18 362-18 365
  • 31 Grishkovskaya I, Avvakumov G V, Sklenar G, Dales D, Hammond G L, Muller Y A. Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain.  EMBO J. 2000;  19 504-512
  • 32 Gershagen S, Fernlund P, Lundwall A. A cDNA coding for human sex hormone binding globulin. Homology to vitamin K-dependent protein S.  FEBS Lett. 1987;  220 129-135
  • 33 Joseph D R, Baker M E. Sex hormone-binding globulin, androgen-binding protein, and vitamin K-dependent protein S are homologous to laminin A, merosin, and Drosophila crumbs protein.  FASEB J. 1992;  6 2477-2481
  • 34 Raineri M, Catalano M G, Hammond G L, Avvakumov G V, Frairia R, Fortunati N. O-Glycosylation of human sex hormone-binding globulin is essential for inhibition of estradiol-induced MCF-7 breast cancer cell proliferation.  Mol Cell Endocrinol. 2002;  189 135-143
  • 35 Fissore F, Fortunati N, Comba A, Fazzari A, Gaidano G, Berta L, Frairia R. The receptor-mediated action of sex steroid binding protein (SBP, SHBG): accumulation of cAMP in MCF-7 cells under SBP and estradiol treatment.  Steroids. 1994;  59 661-667
  • 36 Catalano M G, Comba A, Fazzari A, Benedusi-Pagliano E, Sberveglieri M, Revelli A, Massobrio M, Frairia R, Fortunati N. Sex steroid binding protein receptor (SBP-R) is related to a reduced proliferation rate in human breast cancer.  Breast Cancer Res Treat. 1997;  42 227-234
  • 37 Marquez D C, Pietras R J. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells.  Oncogene. 2001;  20 5420-5430
  • 38 Razandi M, Pedram A, Levin E R. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer.  Mol Endocrinol. 2000;  14 1434-1447
  • 39 Levin E R. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor.  Mol Endocrinol. 2003;  17 309-317. Epub 2002 Dec 12
  • 40 Pearson G, Robinson F, Beers Gibson T, Xu B E, Karandikar M, Berman K, Cobb M H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.  Endocr Rev. 2001;  22 153-183
  • 41 Santen R J, Song R X, McPherson R, Kumar R, Adam L, Jeng M H, Yue W. The role of mitogen-activated protein (MAP) kinase in breast cancer.  J Steroid Biochem Mol Biol. 2002;  80 239-256
  • 42 Freeman S M, Whartenby K A. The role of the mitogen-activated protein kinase cellular signaling pathway in tumor cell survival and apoptosis.  Drug News Perspect. 2004;  17 237-242
  • 43 Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.  Science. 1995;  270 1491-1494
  • 44 Nakhla A M, Khan M S, Rosner W. Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3',5'-monophosphate.  J Clin Endocrinol Metab. 1990;  71 398-404
  • 45 Rosner W, Hryb D J, Khan M S, Nakhla A M, Romas N A. Sex hormone-binding globulin. Binding to cell membranes and generation of a second messenger.  J Androl. 1992;  13 101-106
  • 46 Fortunati N, Fissore F, Fazzari A, Piovano F, Catalano M G, Becchis M, Berta L, Frairia R. Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG).  J Steroid Biochem Mol Biol. 1999;  70 73-80
  • 47 Nakhla A M, Leonard J, Hryb D J, Rosner W. Sex hormone-binding globulin receptor signal transduction proceeds via a G protein.  Steroids. 1999;  64 213-216
  • 48 Fazzari A, Catalano M G, Comba A, Becchis M, Raineri M, Frairia R, Fortunati N. The control of progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone-binding globulin (SHBG).  Mol Cell Endocrinol. 2001;  172 31-36
  • 49 Fortunati N, Fissore F, Fazzari A, Becchis M, Comba A, Catalano M G, Berta L, Frairia R. Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3',5'-monophosphate and protein kinase A.  Endocrinology. 1996;  137 686-692
  • 50 Catalano M G, Frairia R, Boccuzzi G, Fortunati N. Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells.  Mol Cell Endocrinol. 2005;  230 31-37
  • 51 Filardo E J, Quinn J A, Frackelton A R Jr, Bland K I. Estrogen action via the G protein coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.  Mol Endocrinol. 2002;  16 70-84
  • 52 Berkenstam A, Glaumann H, Martin M, Gustafsson J A, Norstedt G. Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells.  Mol Endocrinol. 1989;  3 22-28
  • 53 Jensen B L, Skouv J, Lundholt B K, Lykkesfeldt A E. Differential regulation of specific genes in MCF-7 and the ICI 182 780-resistant cell line MCF-7/182R-6.  Br J Cancer. 1999;  79 386-392
  • 54 Dickson R B, Thompson E W, Lippman M E. Hormones and breast cancer in vitro.  Hum Cell. 1989;  2 219-230
  • 55 Frasor J, Danes J M, Komm B, Chang K CN, Lyttle R, Katzenellenbogen B S. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.  Endocrinology. 2003;  144 4562-4574
  • 56 Thiantanawat A, Long B J, Brodie A M. Signaling pathways of apoptosis activated by aromatase inhbitors and antiestrogens.  Cancer Res. 2003;  63 8037-8050

Nicoletta Fortunati, M. D.

Lab. Endocrinologia Oncologica

Via Genova 3 · 10126 Torino · Italy ·

Fax: +39-011-670.5366

eMail: nfortunati@molinette.piemonte.it